V020-1574 Screening compound: ethyl 6-{[4-(4-fluorobenzoyl)piperazin-1-yl]methyl}-1-methyl-2-oxo-4-(3-phenoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate

V020-1574 Screening compound: ethyl 6-{[4-(4-fluorobenzoyl)piperazin-1-yl]methyl}-1-methyl-2-oxo-4-(3-phenoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate
V020-1574 Screening compound: ethyl 6-{[4-(4-fluorobenzoyl)piperazin-1-yl]methyl}-1-methyl-2-oxo-4-(3-phenoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-1574
ethyl 6-{[4-(4-fluorobenzoyl)piperazin-1-yl]methyl}-1-methyl-2-oxo-4-(3-phenoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-1574

Molecular Formula

C32H33FN4O5 (C32 H33 FN4 O5)

Compound Name

ethyl 6-{[4-(4-fluorobenzoyl)piperazin-1-yl]methyl}-1-methyl-2-oxo-4-(3-phenoxyphenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate

IUPAC name

ethyl 6-{[4-(4-fluorobenzoyl)piperazin-1-yl]methyl}-1-methyl-2-oxo-4-(3-phenoxyphenyl)-1234-tetrahydropyrimidine-5-carboxylate

SMILES

CCOC(C(C(c1cc(Oc2ccccc2)ccc1)N1)=C(CN(CC2)CCN2C(c(cc2)ccc2F)=O)N(C)C1=O)=O

InChI

InChI=1S/C32H33FN4O5/c1-3-41-31(39)28-27(21-36-16-18-37(19-17-36)30(38)22-12-14-24(33)15-13-22)35(2)32(40)34-29(28)23-8-7-11-26(20-23)42-25-9-5-4-6-10-25/h4-15,20,29H,3,16-19,21H2,1-2H3,(H,34,40)/t29-/m1/s1

InChI Key

VCFSMJXAESROQE-GDLZYMKVSA-N

MDL Number (MFCD)

MFCD19809515

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

572.64

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.992

Distribution Coefficient, logD

3.461

Water Solubility, LogSw

-4.04

Polar Surface Area

75.727

Acid Dissociation Constant (pKa)

9.72

Base Dissociation Constant (pKb)

7.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.10

V020-1574 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V020-1574 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-1574?
Check Price and Availability of V020-1574, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-1574 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-1574
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-1574
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-1574 available by request